Henry Schein (NASDAQ:HSIC) Trading 5.1% Higher

Henry Schein, Inc. (NASDAQ:HSIC)’s stock price rose 5.1% during mid-day trading on Wednesday . The company traded as high as $71.50 and last traded at $71.03. Approximately 405,727 shares changed hands during trading, a decline of 62% from the average daily volume of 1,074,627 shares. The stock had previously closed at $67.59.

Analyst Ratings Changes

A number of analysts have weighed in on HSIC shares. Barrington Research restated an “outperform” rating and set a $92.00 price objective on shares of Henry Schein in a research note on Friday, July 5th. Evercore ISI reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research report on Tuesday, July 9th. Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. Finally, UBS Group reduced their target price on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Hold” and an average price target of $80.73.

Henry Schein Stock Up 5.4 %

The company has a market cap of $9.12 billion, a P/E ratio of 23.93, a price-to-earnings-growth ratio of 1.62 and a beta of 0.87. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. The company has a fifty day moving average of $68.53 and a 200 day moving average of $72.07.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. During the same period in the previous year, the company posted $1.21 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, research analysts anticipate that Henry Schein, Inc. will post 5.16 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Henry Schein

A number of hedge funds have recently modified their holdings of HSIC. Beach Investment Counsel Inc. PA purchased a new stake in shares of Henry Schein during the second quarter worth about $37,000. McGlone Suttner Wealth Management Inc. bought a new position in shares of Henry Schein during the 4th quarter valued at approximately $39,000. Mather Group LLC. increased its holdings in shares of Henry Schein by 16.8% in the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after buying an additional 216 shares during the last quarter. Palisade Asset Management LLC purchased a new position in Henry Schein in the first quarter worth about $113,000. Finally, Benjamin F. Edwards & Company Inc. increased its stake in Henry Schein by 37.8% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after acquiring an additional 416 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.